Enzyme Immunoassay (EIA) Reagents and Devices Market Size, Share, Analysis Report

Enzyme Immunoassay (EIA) Reagents and Devices Market By Product Type (Analyzers, Reagents); By Technology Analysis (Enzyme immunoassays, Fluorescent immunoassays, Chemiluminescence immunoassays, Radioimmunoassay); By Application Analysis (Oncology, Infectious diseases, Cardiology, Bone and mineral, Endocrinology, Autoimmunity, Toxicology, Hematology, Neonatal screening); By End User Analysis (Hospitals, Laboratories, Academics, Pharmaceutical industries) and by regional analysis - Global forecast by

The Global Enzyme Immunoassay (EIA) Reagents and Devices Market is expected to be around US$ 7.80 Billion by 2028 at a CAGR of 3.5% in the given forecast period.

Purchase User License

MARKET SNAPSHOT

Major Players

  • Abbott Laboratories
  • Novozymes
  • DSM
  • DuPont
  • Siemens
  • Study period:

    2023-2028

    Base Year:

    2022

    CAGR:

    3

    Fastest Growing Market:

    APAC

    Largest Market:

    North America

    REPORT DESCRIPTION

    Enzyme immunoassay (EIA) Reagents associated Devices are accustomed discover the presence of substance or concentration of an enzyme with its pertinence to epidemiologic diseases detection and immunizing agent trials. The fundamental use is for measure of medication, hormones, specific proteins, tumor markers, and markers of cardiac injury.

    How Big is The Global Enzyme Immunoassay (EIA) Reagents and Devices Market?

    The Global Enzyme Immunoassay (EIA) Reagents and Devices Market is expected to be around US$ 7.80 Billion by 2028 at a CAGR of 3.5% in the given forecast period.

    The major driving factors of Global Enzyme Immunoassay (EIA) Reagents and Devices Market are as follows:

    • Increasing aging population
    • Increasing awareness
    • Novel biomarkers and innovative technologies

    The restraining factors of Global Enzyme Immunoassay (EIA) Reagents and Devices Market ­are as follows:

    • Rising incidence of chronic and infectious diseases
    • Low detection limits

    The Global Enzyme Immunoassay (EIA) Reagents and Devices Market is segmented on the lines of its technology, treatment, application and regional. Based on product type segmentation it covers analyzers and reagents. Based on Technology type it covers enzyme immunoassays, fluorescent immunoassays, chemiluminescence immunoassays, radioimmunoassay, and others. Based on application type it covers oncology, infectious diseases, cardiology, bone and mineral, endocrinology, autoimmunity, toxicology, hematology, neonatal screening and others. Based on end user it covers hospitals, laboratories, academics, pharmaceutical industries and others. Global Enzyme Immunoassay (EIA) Reagents and Devices Market on geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geographic market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries.

    This report provides:
    1) An overview of the global market for Global Enzyme Immunoassay (EIA) Reagents and Devices Market and related technologies.
    2) Analyses of global market trends, with data from 2021, estimates for 2022 and 2023, and projections of compound annual growth rates (CAGRs) through 2028.
    3) Identifications of new market opportunities and targeted promotional plans for Global Enzyme Immunoassay (EIA) Reagents and Devices Market.

    4) Discussion of research and development, and the demand for new products and new applications.
    5) Comprehensive company profiles of major players in the industry.

    Report scope:

    The scope of the report includes a detailed study of Global Enzyme Immunoassay (EIA) Reagents and Devices Market with the reasons given for variations in the growth of the industry in certain regions.

    The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Abbott Laboratories, Novozymes, DSM, DuPont, Siemens, Roche Diagnostics, Danaher Corporation, Ortho Clinical Diagnostics, bioMerieux SA and others. Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.
    The Top Companies Report is intended to provide our buyers with a snapshot of the industry’s most influential players.

    The Global Enzyme Immunoassay (EIA) Reagents and Devices Market has been segmented as below:

    By Product Type:

    • Analyzers 
    • Reagents

    By Technology Analysis:

    • Enzyme immunoassays
    • Fluorescent immunoassays
    • Chemiluminescence immunoassays
    • Radioimmunoassay
    • Others

    By Application Analysis:

    • Oncology
    • Infectious diseases
    • Cardiology
    • Bone and mineral
    • Endocrinology
    • Autoimmunity
    • Toxicology
    • Hematology
    • Neonatal screening
    • Others

    By End User Analysis:

    • Hospitals
    • Laboratories
    • Academics
    • Pharmaceutical industries
    • Others

    By Regional Analysis:

    • North America
    • Europe
    • Asia-Pacific
    • Rest of the World

    Reasons to Buy this Report:
    1) Obtain the most up to date information available on all Global Enzyme Immunoassay (EIA) Reagents and Devices Market

    2) Identify growth segments and opportunities in the industry.

    3) Facilitate decision making on the basis of strong historic and forecast of Global Enzyme Immunoassay (EIA) Reagents and Devices Market.

    4) Assess your competitor’s refining portfolio and its evolution.

    Customization:
    We can offer you custom research reports as per client’s special requirements.

    Below are our new reports:

    Cardiac Rhythm Management Market

    Metabolic Testing Market

    Blood Culture Test Market

    Point-of-Care Testing (POCT) Market

    Request For TOC.

    The Global Enzyme Immunoassay (EIA) Reagents and Devices Market has been segmented as below:

    By Product Type:

    • Analyzers 
    • Reagents

    By Technology Analysis:

    • Enzyme immunoassays
    • Fluorescent immunoassays
    • Chemiluminescence immunoassays
    • Radioimmunoassay
    • Others

    By Application Analysis:

    • Oncology
    • Infectious diseases
    • Cardiology
    • Bone and mineral
    • Endocrinology
    • Autoimmunity
    • Toxicology
    • Hematology
    • Neonatal screening
    • Others

    By End User Analysis:

    • Hospitals
    • Laboratories
    • Academics
    • Pharmaceutical industries
    • Others

    By Regional Analysis:

    • North America
    • Europe
    • Asia-Pacific
    • Rest of the World

    Got a question? We've got answers. If you have some other questions, see our support center.

    The market is expected to grow at a CAGR of 3.5% during the study period (2023-2028)
    The Global Enzyme Immunoassay (EIA) Reagents and Devices Market is expected to be around US$ 7.80 Billion by 2028.
    The segment included in Enzyme Immunoassay (EIA) Reagents and Devices Market is Product, Technology, Application, End User and region.
    Some key players operating in the Enzyme Immunoassay (EIA) Reagents and Devices Market include Abbott Laboratories, Novozymes, DSM, DuPont, Siemens, Roche Diagnostics, Danaher Corporation, Ortho Clinical Diagnostics, bioMerieux SA
    We can offer several formats of the market research reports including, • PDF • PPT • Spreadsheet/ Workbook

    Related Reports